During the past decade, Grupo de Apoio ao Adolescente e a Criança com Cancer conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Grupo de Apoio ao Adolescente e a Criança com Cancer" #1 sponsor was "Grupo de Apoio ao Adolescente e a Crianca com Cancer" with 5 trials, followed by "Children's Oncology Group" with 2 trials sponsored, "Takeda" with 2 trials sponsored, "BioNTech SE" with 1 trials sponsored and "Daiichi Sankyo, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Grupo de Apoio ao Adolescente e a Criança com Cancer" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Imperial College London" with 1 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator, "International BFM Study Group" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Grupo de Apoio ao Adolescente e a Criança com Cancer" are "Acute Lung Injury" (1 trials), "Acute Respiratory Distress Syndrome" (1 trials), "Cancer" (1 trials), "Chronic Myeloid Leukemia" (1 trials) and "Deep Vein Thrombosis (DVT)" (1 trials). Many other conditions were trialed in "Grupo de Apoio ao Adolescente e a Criança com Cancer" in a lesser frequency.

Most popular intervention types in "Grupo de Apoio ao Adolescente e a Criança com Cancer" are "Drug" (7 trials), "Biological" (3 trials), "Procedure" (3 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cisplatin" (3 trials), "Cyclophosphamide" (2 trials), "Doxorubicin Hydrochloride" (2 trials), "Etoposide" (2 trials) and "Filgrastim" (2 trials). Other intervention names were less common.

The vast majority of trials in "Grupo de Apoio ao Adolescente e a Criança com Cancer" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Grupo de Apoio ao Adolescente e a Criança com Cancer". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Grupo de Apoio ao Adolescente e a Criança com Cancer, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Grupo de Apoio ao Adolescente e a Criança com Cancer, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".